Enovis Q2 Earnings Beat, Guidance Reaffirmed — Adjusted EPS $0.90 vs. $0.85 Consensus
ENOV sits 58% above its 52-week low of $19.14.
Summary
Enovis reported Q2 2026 adjusted EPS of $0.90, topping estimates by $0.05, and reaffirmed full-year guidance. Organic sales grew 5%, driven by 6% growth in Reconstructive.
Key Events · Earnings and Guidance · ENOV
-
Q2 Earnings Beat
Adjusted EPS of $0.90 exceeded the $0.85 consensus. Net sales of $583 million grew 3% reported and 5% organic, with Reconstructive up 8% reported.
-
Full-Year Guidance Reaffirmed
Management reiterated 2026 revenue of $2.31-2.37 billion, adjusted EBITDA of $425-435 million, and adjusted EPS of $3.52-3.73, implying confidence in the second half.
-
Margin Expansion
Adjusted EBITDA margin expanded to 17.9% from 16.2% a year ago, reflecting operating leverage and cost discipline.
-
Reconstructive Momentum
Reconstructive segment posted 8% reported growth (6% organic), driven by new product introductions and commercial execution.
Analysis · ENOV · Industrial Applications And Services
A solid quarter from Enovis saw adjusted EPS of $0.90 beat the $0.85 consensus, while organic sales grew 5%. Reaffirming the full-year outlook signals confidence despite a dynamic macro environment. The beat and steady guidance remove near-term uncertainty, though the stock's reaction will hinge on whether investors expected more after recent momentum.
At the time of this filing, ENOV was trading at $30.18 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $19.14 to $34.28. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.